Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Laila Abdel-Kader Martín"'
Autor:
Nerea Báez Gutiérrez, Héctor Rodríguez Ramallo, Elva María Mendoza-Zambrano, Berenice Brown Arreola, Bernardo Santos Ramos, Laila Abdel-kader Martín, Remedios Otero Candelera
Publikováno v:
JMIR mHealth and uHealth, Vol 12, Pp e57289-e57289 (2024)
Abstract BackgroundPulmonary hypertension (PH) is a chronic and complex condition, requiring consistent management and education. The widespread use of smartphones has opened possibilities for mobile health apps to support both patients and health c
Externí odkaz:
https://doaj.org/article/f3857dbca05b4855b01d75bc7496c8e7
Autor:
María Antonia Pérez-Moreno, Pablo Ciudad-Gutiérrez, Didiana Jaramillo-Ruiz, Juan Luis Reguera-Ortega, Laila Abdel-kader Martín, Sandra Flores-Moreno
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 19, p 14780 (2023)
The aim of this paper was to review the available evidence on the efficacy and safety of combined or sequential use of PD-1/PD-L1 immune checkpoint inhibitors (ICI) and CAR-T cell therapies in relapsed/refractory (R/R) haematological malignancies. A
Externí odkaz:
https://doaj.org/article/41a3d8a629034fb9ba29a16625a134e1
Autor:
Nerea Báez Gutiérrez, Héctor Rodríguez Ramallo, Marcos Fernández González, Laila Abdel-Kader Martín
Publikováno v:
JMIR mHealth and uHealth, Vol 10, Iss 10, p e43412 (2022)
Externí odkaz:
https://doaj.org/article/6692d9ce5bac48f4b6fc70dc6239711f
Autor:
Nerea Báez Gutiérrez, Héctor Rodríguez Ramallo, Marcos Fernández González, Laila Abdel-Kader Martín
Publikováno v:
JMIR mHealth and uHealth, Vol 10, Iss 9, p e35851 (2022)
BackgroundHematological malignancies (HMs) are a heterogeneous group of cancers representing a significant cause of morbidity and mortality. The chronification of HMs and the increasing use of smartphones may lead patients to seek their current unmet
Externí odkaz:
https://doaj.org/article/4786500112d7482fb9138fe15c1f75c2
Autor:
Nerea Báez-Gutiérrez, Héctor Rodríguez-Ramallo, María Antonia-Pérez Moreno, Eduardo-Rodriguez Arboli, Laila Abdel-kader Martín
Publikováno v:
Therapeutic Advances in Hematology, Vol 12 (2021)
In recent years, one of the most successful advances in treating acute myeloid leukaemia (AML) has been the combination of the B-cell lymphoma 2 (BCL-2) inhibitor venetoclax with hypomethylating agents (decitabine or azacytidine). This combination tr
Externí odkaz:
https://doaj.org/article/7b23b85c4e4c4ea695dc6b52770cab69
Autor:
Víctor Miguel Nieto García, María Adoración Nieto García, Juan Ramón Lacalle Remigio, Laila Abdel-Kader Martín
Publikováno v:
Revista Española de Salud Pública, Vol 75, Iss 6, Pp 541-550 (2001)
Fundamento: La caries dental tiene una etiología multifactorial en la que intervienen características del huésped (saliva y esmalte dental), de la flora bucal (placa bacteriana) y del substrato sobre el que ésta se desarrolla (higiene oral y d
Externí odkaz:
https://doaj.org/article/3d249c115e214d9e8e23669842c8286f
Autor:
Héctor, Rodríguez-Ramallo, Nerea, Báez-Gutiérrez, Laila, Abdel-Kader-Martín, Remedios, Otero-Candelera
Publikováno v:
Thrombosis Research.
Randomized controlled trials (RCTs) that conduct subgroup analyses have the potential to provide information on treatment decisions in specific groups of patients from heterogeneous populations. Although we understand several factors can modify the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2e3a3e9239e6cf1e02f087b5f4655b9
https://doi.org/10.1016/j.thromres.2022.09.023
https://doi.org/10.1016/j.thromres.2022.09.023
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311678
Introduction: Alectinib is a potent and selective orally active tyrosine kinase inhibitor used for anaplastic lymphoma kinase-positive non-small cell lung cancer, which has a better safety profile than other inhibitors of anaplastic lymphoma kinase.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5524506386d123dbec518fbb07868763
https://doi.org/10.1177/10781552231167808
https://doi.org/10.1177/10781552231167808
Autor:
Sandra Flores‐Moreno, Nerea Báez-Gutiérrez, Laila Abdel-kader Martín, Héctor Rodríguez-Ramallo
Publikováno v:
British Journal of Clinical Pharmacology. 87:2635-2644
Aims To assess the appropriateness of the use and interpretation of subgroup analysis in haematology randomized clinical trials (RCTs). Method A systematic review of Medline, including haematology phase III RCTs published between January 2013 and Oct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c7b88844bbcd8b170f6a3ce4363fef0
https://doi.org/10.1111/bcp.14689
https://doi.org/10.1111/bcp.14689
Autor:
Eduardo-Rodriguez Arboli, Héctor Rodríguez-Ramallo, María Antonia-Pérez Moreno, Nerea Báez-Gutiérrez, Laila Abdel-kader Martín
Publikováno v:
Therapeutic Advances in Hematology, Vol 12 (2021)
Therapeutic Advances in Hematology
Digital.CSIC. Repositorio Institucional del CSIC
instname
Therapeutic Advances in Hematology
Digital.CSIC. Repositorio Institucional del CSIC
instname
In recent years, one of the most successful advances in treating acute myeloid leukaemia (AML) has been the combination of the B-cell lymphoma 2 (BCL-2) inhibitor venetoclax with hypomethylating agents (decitabine or azacytidine). This combination tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b5bbf927a25839700fef02bf5465229
https://hdl.handle.net/10668/4453
https://hdl.handle.net/10668/4453
